108 related articles for article (PubMed ID: 20876772)
1. The B cell in atherosclerosis: teaming up with the bad guys?
Nilsson J; Fredrikson GN
Clin Chem; 2010 Dec; 56(12):1789-91. PubMed ID: 20876772
[No Abstract] [Full Text] [Related]
2. B cell depletion reduces the development of atherosclerosis in mice.
Ait-Oufella H; Herbin O; Bouaziz JD; Binder CJ; Uyttenhove C; Laurans L; Taleb S; Van Vré E; Esposito B; Vilar J; Sirvent J; Van Snick J; Tedgui A; Tedder TF; Mallat Z
J Exp Med; 2010 Aug; 207(8):1579-87. PubMed ID: 20603314
[TBL] [Abstract][Full Text] [Related]
3. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD20 monoclonal antibodies: beyond B-cells.
Avivi I; Stroopinsky D; Katz T
Blood Rev; 2013 Sep; 27(5):217-23. PubMed ID: 23953071
[TBL] [Abstract][Full Text] [Related]
5. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
[TBL] [Abstract][Full Text] [Related]
6. Follicular B Cells Promote Atherosclerosis via T Cell-Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G.
Tay C; Liu YH; Kanellakis P; Kallies A; Li Y; Cao A; Hosseini H; Tipping P; Toh BH; Bobik A; Kyaw T
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):e71-e84. PubMed ID: 29599140
[TBL] [Abstract][Full Text] [Related]
7. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response.
Grasset EK; Duhlin A; Agardh HE; Ovchinnikova O; Hägglöf T; Forsell MN; Paulsson-Berne G; Hansson GK; Ketelhuth DF; Karlsson MC
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2030-8. PubMed ID: 25848033
[TBL] [Abstract][Full Text] [Related]
8. The role of T and B cells in atherosclerosis: potential clinical implications.
Dumitriu IE; Kaski JC
Curr Pharm Des; 2011 Dec; 17(37):4159-71. PubMed ID: 22204376
[TBL] [Abstract][Full Text] [Related]
9. Vaccination Strategies and Immune Modulation of Atherosclerosis.
Nilsson J; Hansson GK
Circ Res; 2020 Apr; 126(9):1281-1296. PubMed ID: 32324498
[TBL] [Abstract][Full Text] [Related]
10. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
[TBL] [Abstract][Full Text] [Related]
11. Depletion of B cells in murine lupus: efficacy and resistance.
Ahuja A; Shupe J; Dunn R; Kashgarian M; Kehry MR; Shlomchik MJ
J Immunol; 2007 Sep; 179(5):3351-61. PubMed ID: 17709552
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC
Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
[TBL] [Abstract][Full Text] [Related]
14. CD44-deficiency on hematopoietic cells limits T-cell number but does not protect against atherogenesis in LDL receptor-deficient mice.
Sjöberg S; Eriksson EE; Tivesten A; Carlsson A; Klasson A; Levin M; Borén J; Krettek A
Atherosclerosis; 2009 Oct; 206(2):369-74. PubMed ID: 19345948
[TBL] [Abstract][Full Text] [Related]
15. B-cell: a logical target for treatment of rheumatoid arthritis.
Youinou P; Jamin C; Saraux A
Clin Exp Rheumatol; 2007; 25(2):318-28. PubMed ID: 17543163
[TBL] [Abstract][Full Text] [Related]
16. Immunity in Atherosclerosis: Focusing on T and B Cells.
Poznyak AV; Bezsonov EE; Popkova TV; Starodubova AV; Orekhov AN
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445084
[TBL] [Abstract][Full Text] [Related]
17. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
18. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Tervaert JW
Autoimmun Rev; 2009 Sep; 9(1):53-7. PubMed ID: 19285155
[TBL] [Abstract][Full Text] [Related]
20. ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.
Ley K; Gerdes N; Winkels H
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):764-777. PubMed ID: 28360089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
